This is a preview of subscription content, log in via an institution to check access.
Notes
Direct medical, direct nonmedical and indirect costs were included; all costs were converted to 2019 US dollars, and costs and QALYs were discounted at 3% per annum.
willingness to pay
Reference
Liu D, et al. Cost-effectiveness of strategies for preventing paediatric lower respiratory infections associated with respiratory syncytial virus in eight Chinese cities. Vaccine : 25 Aug 2021. Available from: URL: http://doi.org/10.1016/j.vaccine.2021.08.057
Rights and permissions
About this article
Cite this article
Vaccination to prevent RSV in China could be cost effective, depending on price and season. PharmacoEcon Outcomes News 887, 29 (2021). https://doi.org/10.1007/s40274-021-08045-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-021-08045-0